IL158534A0 - Oligonucletide compositions and their use to induce differentation of cells - Google Patents

Oligonucletide compositions and their use to induce differentation of cells

Info

Publication number
IL158534A0
IL158534A0 IL15853402A IL15853402A IL158534A0 IL 158534 A0 IL158534 A0 IL 158534A0 IL 15853402 A IL15853402 A IL 15853402A IL 15853402 A IL15853402 A IL 15853402A IL 158534 A0 IL158534 A0 IL 158534A0
Authority
IL
Israel
Prior art keywords
cells
compositions
seq
differentiation
induce
Prior art date
Application number
IL15853402A
Other languages
English (en)
Original Assignee
Bioniche Life Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioniche Life Sciences Inc filed Critical Bioniche Life Sciences Inc
Publication of IL158534A0 publication Critical patent/IL158534A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/117—Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/18—Type of nucleic acid acting by a non-sequence specific mechanism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Saccharide Compounds (AREA)
IL15853402A 2001-04-24 2002-04-23 Oligonucletide compositions and their use to induce differentation of cells IL158534A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28615801P 2001-04-24 2001-04-24
US10/127,645 US7087586B2 (en) 2001-04-24 2002-04-22 Oligonucleotide compositions and their use to induce differentiation of cells
PCT/CA2002/000573 WO2002085340A2 (en) 2001-04-24 2002-04-23 Oligonucleotide compositions and their use to induce differentiation of cells

Publications (1)

Publication Number Publication Date
IL158534A0 true IL158534A0 (en) 2004-05-12

Family

ID=26825829

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15853402A IL158534A0 (en) 2001-04-24 2002-04-23 Oligonucletide compositions and their use to induce differentation of cells
IL158534A IL158534A (en) 2001-04-24 2003-10-21 Oligonucleotide compositions and their use to induce cell differentiation

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL158534A IL158534A (en) 2001-04-24 2003-10-21 Oligonucleotide compositions and their use to induce cell differentiation

Country Status (12)

Country Link
US (2) US7087586B2 (xx)
EP (1) EP1381375B1 (xx)
JP (1) JP4460220B2 (xx)
KR (1) KR100913860B1 (xx)
AT (1) ATE489467T1 (xx)
AU (1) AU2002252891B2 (xx)
CA (1) CA2445071A1 (xx)
DE (1) DE60238393D1 (xx)
IL (2) IL158534A0 (xx)
MX (1) MXPA03009761A (xx)
NZ (1) NZ529160A (xx)
WO (1) WO2002085340A2 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100971571B1 (ko) * 2001-10-03 2010-07-20 바이오니취 라이프 사이언시즈 인코포레이티드 치료적으로 유용한 트리에틸렌글리콜 콜레스테릴올리고뉴클레오타이드
EP1497424A1 (en) * 2002-04-22 2005-01-19 Bioniche Life Sciences Inc. Oligonucleotide compositions and their use for the modulation of immune responses
US20050101576A1 (en) * 2003-11-06 2005-05-12 Novacea, Inc. Methods of using vitamin D compounds in the treatment of myelodysplastic syndromes
WO2007028985A2 (en) * 2005-09-07 2007-03-15 The Secretary Of State For Defence Adjuvanted vaccine
WO2009143292A2 (en) * 2008-05-21 2009-11-26 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of treating pneumoconiosis with oligodeoxynucleotides
US8053422B2 (en) 2008-12-04 2011-11-08 The United States Of America As Represented By The Department Of Health And Human Services Anti-cancer oligodeoxynucleotides
GB0906234D0 (en) 2009-04-14 2009-05-20 Secr Defence Vaccine

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567604A (en) * 1993-04-23 1996-10-22 Aronex Pharmaceuticals, Inc. Anti-viral guanosine-rich oligonucleotides
US5866332A (en) * 1994-02-02 1999-02-02 Incyte Pharmaceuticals, Inc. Human myeloid terminal differentiation response gene
US5994320A (en) * 1995-02-06 1999-11-30 Regents Of The University Of Minnesota Antisense oligonucleotides and methods for treating central nervous system tumors
US5851984A (en) * 1996-08-16 1998-12-22 Genentech, Inc. Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides
WO1999058118A2 (en) * 1998-05-14 1999-11-18 Cpg Immunopharmaceuticals Gmbh METHODS FOR REGULATING HEMATOPOIESIS USING CpG-OLIGONUCLEOTIDES
WO2001044465A2 (en) * 1999-12-13 2001-06-21 Bioniche Life Sciences Inc. Therapeutically useful synthetic oligonucleotides
US20020091095A1 (en) * 1999-12-13 2002-07-11 Phillips Nigel C. Modulation of Fas and FasL expression
JP4215429B2 (ja) 1999-12-28 2009-01-28 バイオニケ ライフ サイエンシーズ インコーポレイテッド 癌治療におけるヒアルロン酸
MXPA03001812A (es) * 2000-08-29 2004-05-21 Bioniche Life Sciences Inc Modulacion de la expresion del sindrome de alcohol fetal y del ligando del sindrome de alcohol fetal..
MXPA04001480A (es) * 2001-08-17 2004-05-20 Bioniche Life Sciences Inc Composiciones de oligonucleotido y su uso para inducir apoptosis.

Also Published As

Publication number Publication date
JP4460220B2 (ja) 2010-05-12
US20070010472A1 (en) 2007-01-11
ATE489467T1 (de) 2010-12-15
CA2445071A1 (en) 2002-10-31
KR100913860B1 (ko) 2009-08-26
AU2002252891B2 (en) 2007-09-20
JP2004526775A (ja) 2004-09-02
WO2002085340A2 (en) 2002-10-31
EP1381375B1 (en) 2010-11-24
NZ529160A (en) 2006-06-30
KR20040047749A (ko) 2004-06-05
MXPA03009761A (es) 2004-01-29
US7087586B2 (en) 2006-08-08
US20030045493A1 (en) 2003-03-06
WO2002085340A3 (en) 2003-10-30
EP1381375A2 (en) 2004-01-21
DE60238393D1 (de) 2011-01-05
IL158534A (en) 2010-06-16

Similar Documents

Publication Publication Date Title
EP2186525A3 (en) G-CSF for use in the treatment of Parkinson's disease
ATE300613T1 (de) Menschliche, für zyklische nukleotide spezifische phosphodiesterase
ES2375058T8 (es) Axmi-010, un gen de la delta-endotoxina y métodos para su uso.
WO2002102997A3 (en) Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same
EP1947184A3 (en) Delta-endotoxin genes and methods for their use
EP1778842B8 (en) Compositions and methods of use for mgd-csf in disease treatment
NZ331815A (en) A method for preparing cell lines that have artificial chromosomes, uses thereof and methods for preparing artificial chromosomes in particular they are satellite artificial chromosomes that are composed of heterochromatin and the inserted heterologous DNA
RU2006135131A (ru) Улучшенные мутеины интерлейкина-2
SG127738A1 (en) Heterocyclic compounds based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, pharmaceutical preparations containing these compounds
BR9206027A (pt) Análogo de oligonucleotídio, composto de subunidade de oligonucleotídeo, processo para preparar tal composto, processo para modular a produção ou atividade de uma proteína, e, processo para tratar um organismo tendo uma doença distinta pela produção indesejada de uma proteína
WO2005021585A3 (en) Axmi-003, a delta-endotoxin gene and methods for its use
AU9084601A (en) G-csf analog compositions and methods
BG102973A (en) LIGAND RET (RetL) FOR THE STIMULATION OF THE NERVE AND RENAL GROWTH
IL176268A0 (en) Use of alginate matrices to control cell growth
IL158534A0 (en) Oligonucletide compositions and their use to induce differentation of cells
JPS6423858A (en) Animal feed additive, feed containing the same and animal growth improving method
ATE190352T1 (de) Dorsalgewebe beeinflussender faktor und zusammensetzungen
CY1106041T1 (el) Καινοφανης συλλεκτινη
ES2173856T3 (es) Proceso para la preparacion de vectores geneticos para la expresion del factor de crecimiento nervioso en celulas eucariotas.
PL365473A1 (en) Polyamine analogues as cytotoxic agents
PL346143A1 (en) Tan-1057 derivatives
HUP0300219A2 (hu) L-nukleozidokat, L-nukleotidokat és analógjaikat tartalmazó készítmények és alkalmazásuk
EP1036842A3 (en) Use of cyanobacterial fructose-1,6-bisphosphatase to improve growth of plants
DE60100855D1 (de) 1,8-naphthalimid imidazo[4,5,1-de]acridone mit antitumorwirkung
AU4884001A (en) Novel collectins